[Genetics, Diagnostics and Clinical Presentation of Primary Lymphoedema]

Overview

Journal Dermatologie (Heidelb)

Specialty Dermatology

Date 2023 Jul 4

PMID 37402871

Authors

Rene Hagerling

Affiliations

Soon will be listed here.

Abstract

Primary lymphoedema is a hereditary genetic disorder of the lymphatic system. These genetic disorders can result in malformation or dysfunction of the lymphatic system, which leads to an accumulation of fluid in the tissue and, thus to the formation of oedema. The most common form is peripheral lymphoedema of the lower limbs, but systemic manifestations such as intestinal lymphangiectasia, ascites, chylothorax or hydrops fetalis may also occur. The clinical presentation and the degree of lymphoedema varies depending on the causative gene and the specific gene alteration. Primary lymphoedema is divided into five categories: (1) disorders with somatic mosaicism and segmental growth abnormality, (2a) syndromal disorders, (2b) disorders with systemic involvement, (2c) congenital lymphoedema and (2d) disorders that occur after the first year of life (late onset lymphoedema). Targeted genetic diagnosis is based on the patient's clinical presentation and classification into one of the five categories. In general, the diagnosis usually starts with basic diagnostics, which include cytogenetic and molecular genetic testing. Subsequently, a molecular genetic diagnosis is made by performing single-gene analyses, gene panel examinations, exome sequencing or whole genome sequencing. This allows the identification of genetic variants or mutations that are considered to be causative for the presenting symptoms. Combined with human genetic counselling, the genetic diagnosis allows for conclusions about inheritance, the risk of recurrence and potential concomitant symptoms. In many cases, only this approach allows the definite form of primary lymphoedema to be described.

References

Connell F, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer P . The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013; 84(4):303-14. DOI: 10.1111/cge.12173. View

Gordon K, Varney R, Keeley V, Riches K, Jeffery S, van Zanten M . Update and audit of the St George's classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis. J Med Genet. 2020; 57(10):653-659. PMC: 7525776. DOI: 10.1136/jmedgenet-2019-106084. View

Kurek K, Luks V, Ayturk U, Alomari A, Fishman S, Spencer S . Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet. 2012; 90(6):1108-15. PMC: 3370283. DOI: 10.1016/j.ajhg.2012.05.006. View

Cohen Jr M . Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet. 2013; 85(2):111-9. DOI: 10.1111/cge.12266. View

Rodriguez-Laguna L, Ibanez K, Gordo G, Garcia-Minaur S, Santos-Simarro F, Agra N . CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype. Genet Med. 2018; 20(8):882-889. DOI: 10.1038/gim.2017.200. View

Alitalo K . The lymphatic vasculature in disease. Nat Med. 2011; 17(11):1371-80. DOI: 10.1038/nm.2545. View

Martin-Almedina S, Mortimer P, Ostergaard P . Development and physiological functions of the lymphatic system: insights from human genetic studies of primary lymphedema. Physiol Rev. 2021; 101(4):1809-1871. DOI: 10.1152/physrev.00006.2020. View

Morgan T . Turner syndrome: diagnosis and management. Am Fam Physician. 2007; 76(3):405-10. View

Roberts A, Allanson J, Tartaglia M, Gelb B . Noonan syndrome. Lancet. 2013; 381(9863):333-42. PMC: 4267483. DOI: 10.1016/S0140-6736(12)61023-X. View

10.

Paznekas W, Karczeski B, Vermeer S, Lowry R, Delatycki M, Laurence F . GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat. 2009; 30(5):724-33. DOI: 10.1002/humu.20958. View

11.

Ostergaard P, Simpson M, Connell F, Steward C, Brice G, Woollard W . Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011; 43(10):929-31. DOI: 10.1038/ng.923. View

12.

Hagerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, Adams R . A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J. 2013; 32(5):629-44. PMC: 3590982. DOI: 10.1038/emboj.2012.340. View

13.

Fotiou E, Martin-Almedina S, Simpson M, Lin S, Gordon K, Brice G . Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015; 6:8085. PMC: 4568316. DOI: 10.1038/ncomms9085. View

14.

Brice G, Child A, Evans A, Bell R, Mansour S, Burnand K . Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005; 42(2):98-102. PMC: 1735984. DOI: 10.1136/jmg.2004.024802. View

15.

Gordon K, Schulte D, Brice G, Simpson M, Roukens M, van Impel A . Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res. 2013; 112(6):956-60. DOI: 10.1161/CIRCRESAHA.113.300350. View

16.

Ferrell R, Baty C, Kimak M, Karlsson J, Lawrence E, Franke-Snyder M . GJC2 missense mutations cause human lymphedema. Am J Hum Genet. 2010; 86(6):943-8. PMC: 3032064. DOI: 10.1016/j.ajhg.2010.04.010. View

17.

Lampejo A, Ghavimi S, Hagerling R, Agarwal S, Murfee W . Lymphatic/blood vessel plasticity: motivation for a future research area based on present and past observations. Am J Physiol Heart Circ Physiol. 2022; 324(1):H109-H121. PMC: 9829479. DOI: 10.1152/ajpheart.00612.2022. View

18.

Alders M, Hogan B, Gjini E, Salehi F, Al-Gazali L, Hennekam E . Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009; 41(12):1272-4. DOI: 10.1038/ng.484. View